BioCryst Pharmaceuticals (BCRX): Q4 EPS of -$0.29 beats by $0.04. Revenue of $5.2M (-68.9% Y/Y)...

|About: BioCryst Pharmaceutical... (BCRX)|By:, SA News Editor
BioCryst Pharmaceuticals (BCRX): Q4 EPS of -$0.29 beats by $0.04. Revenue of $5.2M (-68.9% Y/Y) misses by $2.2M. (PR)